|
DENND4C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.405800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.519800E-01 |
| Normal-vs-Stage2 |
2.453800E-01 |
| Normal-vs-Stage3 |
9.705600E-01 |
| Normal-vs-Stage4 |
7.844400E-01 |
| Stage1-vs-Stage2 |
1.930240E-01 |
| Stage1-vs-Stage3 |
8.570200E-01 |
| Stage1-vs-Stage4 |
8.405000E-01 |
| Stage2-vs-Stage3 |
4.507400E-01 |
| Stage2-vs-Stage4 |
3.454200E-01 |
| Stage3-vs-Stage4 |
8.080000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.763400E-01 |
| Normal-vs-AfricanAmerican |
5.952000E-01 |
| Normal-vs-Asian |
8.545000E-01 |
| Caucasian-vs-AfricanAmerican |
6.328000E-01 |
| Caucasian-vs-Asian |
8.540600E-01 |
| AfricanAmerican-vs-Asian |
9.810600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.686600E-01 |
| Normal-vs-Female |
3.655600E-02 |
| Male-vs-Female |
1.041850E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.782400E-01 |
| Normal-vs-Extreme_Weight |
2.596200E-01 |
| Normal-vs-Obese |
2.628000E-01 |
| Normal-vs-Extreme_Obese |
6.888000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.432800E-01 |
| Normal_Weight-vs-Obese |
2.244400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.615600E-01 |
| Extreme_Weight-vs-Obese |
5.403700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.351400E-01 |
| Obese-vs-Extreme_Obese |
4.003600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.026040E-01 |
| Normal-vs-Age(41-60Yrs) |
1.924960E-01 |
| Normal-vs-Age(61-80Yrs) |
2.952000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.602400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.034200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.837500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.382400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.186200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.674600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.981600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.381400E-01 |
| Normal-VS-Type2 PRCC |
8.094300E-02 |
| Normal-VS-KIRP CIMP |
1.824460E-02 |
| Normal-VS-Unclassified PRCC |
7.678200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.612180E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.212300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.942400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.015600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.499040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.579100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.468610E-01 |
| Normal-vs-N1 |
7.675200E-01 |
| Normal-vs-N2 |
2.248000E-01 |
| N0-vs-N1 |
3.535800E-01 |
| N0-vs-N2 |
7.756800E-01 |
| N1-vs-N2 |
5.790800E-01 |
|
|
